🇺🇸 FDA
Pipeline program

Toripalimab + Chemotherapy

J2537

Phase 2 small_molecule active

Quick answer

Toripalimab + Chemotherapy for Head and Neck Cancer is a Phase 2 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Coherus Oncology
Indication
Head and Neck Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials